Johnson and Johnson to pay $6.3 million as part of Infant Tylenol settlement

Johnson and Johnson has agreed to pay $6.3 million as part of a class-action lawsuit to customers who have purchased Infant Tylenol since 2014.

The company was accused of deceptive packaging -- advertising the product as uniquely formulated for infants. However it had the same concentration as the children's version, according to the lawsuit.